SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
- Status
- RECRUITING
- Phase
- PHASE1
RegoNivo vs Standard of Care Chemotherapy in AGOC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy of Hyperthermic Intraperitoneal Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE3
c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI
- Status
- UNKNOWN
- Phase
- PHASE2
iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB
- Status
- RECRUITING
- Phase
- PHASE3
Docetaxel and Irinotecan in Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE3
5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2